CA-106T

N/A

Report date: 2024/12/12 10:42:59

Base Information

Drug NameCA-106T
Drug Alias NameCA-106-TCA106-T
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsMyc proto-oncogene protein inhibitors
TargetsApoptosis regulator Bcl-2Myc proto-oncogene protein
Therapy Area/IndicationsLung NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCurigin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCurigin Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A